Ovid Therapeutics (OVID) EPS (Basic) (2016 - 2026)
Ovid Therapeutics' (OVID) quarterly EPS (Basic) came in at -$0.12 in Q1 2026, up 13.4% YoY from -$0.11 in Q1 2025, and down 195.2% on a QoQ basis from $0.13 in Q4 2025.
Ovid Therapeutics (OVID) EPS (Basic) (2016 - 2026) Analysis & Trends
Ovid Therapeutics (OVID) has 11 years of EPS (Basic) data on file, last reported at -$0.12 in Q1 2026.
- Quarterly EPS (Basic) rose 13.4% year-over-year to -$0.12 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.18 (up 49.51% YoY) and the FY2025 annual result came in at -$0.24, up 36.65% from the prior year.
- EPS (Basic) declined to -$0.12 in Q1 2026, from $0.13 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.13 in Q4 2025 to a low of -$0.23 in Q1 2022.
- A 5-year average of -$0.13 and a median of -$0.17 in 2024 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 200.42% in 2025, down 154.82% in 2025.
- Tracing OVID's EPS (Basic) over 5 years: stood at -$0.16 in 2022, then plunged by 32.89% to -$0.22 in 2023, then jumped by 39.89% to -$0.13 in 2024, then surged by 200.42% to $0.13 in 2025, then sank by 195.2% to -$0.12 in 2026.
- The last three EPS (Basic) figures came in at -$0.12 (Q1 2026), $0.13 (Q4 2025), and -$0.17 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Ovid Therapeutics | 385.37 Mn | 229.84 Mn | - | -0.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.12 |
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | -0.17 |
| Jun 30, 2025 | -0.07 |
| Mar 31, 2025 | -0.14 |
| Dec 31, 2024 | -0.13 |
| Sep 30, 2024 | -0.20 |
| Jun 30, 2024 | 0.12 |
| Mar 31, 2024 | -0.17 |
| Dec 31, 2023 | -0.22 |
| Sep 30, 2023 | -0.16 |
| Jun 30, 2023 | -0.18 |
| Mar 31, 2023 | -0.19 |
| Dec 31, 2022 | -0.16 |
| Sep 30, 2022 | -0.17 |
| Jun 30, 2022 | -0.21 |
| Mar 31, 2022 | -0.23 |
| Dec 31, 2021 | -0.39 |
| Sep 30, 2021 | -0.17 |
| Jun 30, 2021 | -0.23 |